Updates are available Correction dated 2022-07-19
Click to view Correction: https://doi.org/10.1038/s41590-022-01286-z
-
Authors
Mirchandani, Ananda S. http://orcid.org/0000-0002-5492-1687
Jenkins, Stephen J. http://orcid.org/0000-0002-0233-5424
Bain, Calum C. http://orcid.org/0000-0001-8884-327X
Sanchez-Garcia, Manuel A.
Lawson, Hannah
Coelho, Patricia
Murphy, Fiona
Griffith, David M. http://orcid.org/0000-0001-9500-241X
Zhang, Ailiang
Morrison, Tyler
Ly, Tony
Arienti, Simone http://orcid.org/0000-0002-5406-0012
Sadiku, Pranvera
Watts, Emily R.
Dickinson, Rebecca. S.
Reyes, Leila
Cooper, George http://orcid.org/0000-0002-3652-3837
Clark, Sarah
Lewis, David
Kelly, Van
Spanos, Christos
Musgrave, Kathryn M.
Delaney, Liam http://orcid.org/0000-0003-2894-1622
Harper, Isla http://orcid.org/0000-0003-1736-2545
Scott, Jonathan
Parkinson, Nicholas J. http://orcid.org/0000-0001-6336-5654
Rostron, Anthony J.
Baillie, J. Kenneth http://orcid.org/0000-0001-5258-793X
Clohisey, Sara http://orcid.org/0000-0001-7489-9846
Pridans, Clare http://orcid.org/0000-0001-9423-557X
Campana, Lara
Lewis, Philip Starkey
Simpson, A. John
Dockrell, David H. http://orcid.org/0000-0002-2718-4861
Schwarze, Jürgen
Hirani, Nikhil http://orcid.org/0000-0001-8854-3605
Ratcliffe, Peter J.
Pugh, Christopher W.
Kranc, Kamil
Forbes, Stuart J. http://orcid.org/0000-0003-3715-2561
Whyte, Moira K. B. http://orcid.org/0000-0001-7788-1852
Walmsley, Sarah R. http://orcid.org/0000-0001-9584-174X
-
Funding
Funding for this research was provided by:
Wellcome Trust (110086, PIII052, 206234/Z/17/Z, 098516, 209220)
Cancer Research UK (C29967A/14633, C29967/A26787)
UKRI/NIHR UK Coronavirus Immunology Consortium (UK-CIC).
- License Information
-
More Information
Article History
Received: 4 April 2021
Accepted: 18 April 2022
First Online: 27 May 2022
Change Date: 19 July 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41590-022-01286-z
Competing interests
: A.S.M., S.R.W., M.K.W., S.J.F. and S.J.J. have filed a patent for the use of CSF-1 as a therapy in ARDS with the University of Edinburgh (PCT/GB/2020/051184).
